论文部分内容阅读
目的:观察米非司酮联合理气活血中药组方治疗子宫肌瘤的临床疗效。方法:将98例患者随机分为3组,米非司酮组33例予米非司酮治疗;中药组32例予理气活血中药组方治疗;联合用药组33例予米非司酮联合理气活血中药组方治疗。疗程均为90天,观察各组用药前后子宫肌瘤大小和体内激素水平变化。结果:治疗后各组患者子宫体积和子宫肌瘤体积均较治疗前缩小(P<0.01);联合用药组子宫体积、子宫肌瘤体积较其他2组缩小更明显(P<0.05)。治疗后各组患者FSH、P、LH、E2、PRL均较治疗前降低,差异有显著性意义(P<0.05);联合用药组与米非司酮组比较,血清P、LH、E2水平降低更为显著(P<0.05);联合用药组与中药组比较,血清FSH、P、LH、E2水平降低更为显著(P<0.05)。结论:中药组方联合米非司酮治疗子宫肌瘤,临床疗效确切。
Objective: To observe the clinical efficacy of mifepristone combined with qi and activating blood circulation prescription in treating uterine fibroids. Methods: 98 patients were randomly divided into three groups, mifepristone group, 33 cases to mifepristone treatment; 32 cases of traditional Chinese medicine group to qi and activating blood Chinese medicine treatment group; combination group, 33 cases of mifepristone combined with qi Huoxue medicine group treatment. The course of treatment was 90 days. The changes of uterine leiomyoma size and hormone level before and after treatment in each group were observed. Results: The volume of uterine fibroids and the volume of uterine fibroids in all the groups were decreased after treatment (P <0.01). The volume of uterine fibroids and uterine fibroids in the combination group contracted more significantly than the other two groups (P <0.05). After treatment, the levels of FSH, P, LH, E2 and PRL in all the groups were significantly lower than those before treatment (P <0.05). Compared with the mifepristone group, the levels of serum P, LH and E2 were decreased (P <0.05). Compared with the traditional Chinese medicine group, the serum FSH, P, LH and E2 levels decreased more significantly (P <0.05). Conclusion: The combination of traditional Chinese medicine and mifepristone treatment of uterine fibroids, clinical curative effect.